Breaching peripheral tolerance promotes the production of HIV-1–neutralizing antibodies
暂无分享,去创建一个
Scott B. Thompson | M. Santiago | R. Pelanda | R. Torres | Roberta Pelanda | K. Schroêder | Raul M. Torres | Kristin M.S. Schroeder | Amanda Agazio | Pamela Strauch | Sean T. Jones | Michael S. Harper | Mario L. Santiago | Pamela Strauch | S. Thompson | Amanda Agazio | Michael S Harper | Sean T Jones
[1] B. Haynes,et al. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. , 2011, Current opinion in immunology.
[2] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[3] A. Feeney,et al. Repertoire-based selection into the marginal zone compartment during B cell development , 2008, The Journal of experimental medicine.
[4] B. Chesebro,et al. Apobec3 Encodes Rfv3, a Gene Influencing Neutralizing Antibody Control of Retrovirus Infection , 2008, Science.
[5] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[6] D. Burton,et al. Immune Tolerance Negatively Regulates B Cells in Knock-In Mice Expressing Broadly Neutralizing HIV Antibody 4E10 , 2013, The Journal of Immunology.
[7] M. Satoh,et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane , 2000, Clinical and experimental immunology.
[8] R. Palacios,et al. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature , 2002, Lupus.
[9] William C. Olson,et al. Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.
[10] Ron Diskin,et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.
[11] R. Perlmutter,et al. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. , 1997, International immunology.
[12] Renate Kunert,et al. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies , 2005, Science.
[13] L. Wysocki,et al. Identification of anergic B cells within a wild-type repertoire. , 2006, Immunity.
[14] David Nemazee,et al. Receptor editing in lymphocyte development and central tolerance , 2006, Nature Reviews Immunology.
[15] John P. Moore,et al. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity , 2015, Journal of Virology.
[16] B. R. Kaye. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). , 1989, Annals of internal medicine.
[17] L. Stamatatos,et al. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates. , 2000, AIDS research and human retroviruses.
[18] N. Olsen,et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes , 2006, Clinical and experimental immunology.
[19] Retraction Kiehntopf,et al. Retraction , 1997, Concurr. Comput. Pract. Exp..
[20] C. Goodnow,et al. Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization , 2016, The Journal of experimental medicine.
[21] R. Pelanda,et al. Division of labor during primary humoral immunity , 2013, Immunologic research.
[22] J. Moore,et al. Targeting HIV-1 envelope glycoprotein trimers to B cells using APRIL improves antibody responses , 2012, Retrovirology.
[23] P. Simmonds,et al. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue , 2012, Retrovirology.
[24] J. Mascola,et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques , 2014, The Journal of experimental medicine.
[25] G. Debnath,et al. D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .
[26] T. Kepler,et al. Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages , 2016, Science Translational Medicine.
[27] J. Binley,et al. Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses , 2011, Journal of Virology.
[28] L. Stamatatos,et al. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor , 1997, Journal of virology.
[29] B. Haynes,et al. Polyreactivity and Autoreactivity among HIV-1 Antibodies , 2014, Journal of Virology.
[30] R. Pelanda,et al. Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice , 2012, The Journal of experimental medicine.
[31] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[32] Robin A. Weiss,et al. Neutralizing antibodies to HIV-1 induced by immunization , 2013, The Journal of experimental medicine.
[33] P. Sharp,et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation , 1992, Journal of virology.
[34] P. Marrack,et al. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity , 2012, Proceedings of the National Academy of Sciences.
[35] David Baltimore,et al. Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis , 2011, Nature.
[36] H. Liao,et al. Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance , 2009, Proceedings of the National Academy of Sciences.
[37] J. Mascola,et al. BLyS-Mediated Modulation of Naive B Cell Subsets Impacts HIV Env-Induced Antibody Responses , 2012, The Journal of Immunology.
[38] H. Liao,et al. Induction of HIV-1 Broad Neutralizing Antibodies in 2F5 Knock-in Mice: Selection against Membrane Proximal External Region–Associated Autoreactivity Limits T-Dependent Responses , 2013, The Journal of Immunology.
[39] D. Klinman. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. , 1990, The Journal of clinical investigation.
[40] J. Kappes,et al. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes , 1991, Journal of virology.
[41] Philippa Marrack,et al. Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity1 , 2009, The Journal of Immunology.
[42] John P. Moore,et al. Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[43] M. McCarter,et al. Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies , 2013, Proceedings of the National Academy of Sciences.
[44] N. Olsen,et al. Risk factors for ANA positivity in healthy persons , 2011, Arthritis Research & Therapy.
[45] T. Kepler,et al. An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. , 2014, The Journal of clinical investigation.
[46] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[47] C. Goodnow,et al. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity , 2014, Proceedings of the National Academy of Sciences.
[48] R. Pelanda,et al. Receptor editing for better or for worse. , 2006, Current opinion in immunology.
[49] J. Levine,et al. Looking at Child Labor , 2002, Science.
[50] J. D. Capra,et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. , 2007, The Journal of clinical investigation.
[51] Florian Klein,et al. Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy , 2014, Cell.
[52] Hongmei Gao,et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. , 2014, Journal of immunological methods.
[53] TA Kion,et al. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice , 1991, Science.
[54] S. Gauld,et al. B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.
[55] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[56] Maxim N. Artyomov,et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation , 2010, Nature.
[57] E. Wakeland,et al. Polygenic control of susceptibility to murine systemic lupus erythematosus. , 1994, Immunity.
[58] B. Haynes,et al. Rescue of HIV-1 Broad Neutralizing Antibody-Expressing B Cells in 2F5 VH × VL Knockin Mice Reveals Multiple Tolerance Controls , 2011, The Journal of Immunology.
[59] Dennis R Burton,et al. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. , 2016, Annual review of immunology.
[60] Y. Shoenfeld,et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum , 2013, Expert review of clinical immunology.
[61] John P. Moore,et al. Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes , 2015, Cell.
[62] Kindra M Kelly-Scumpia,et al. Colocalization of Antigen-Specific B and T Cells within Ectopic Lymphoid Tissue following Immunization with Exogenous Antigen1 , 2008, The Journal of Immunology.
[63] T. Ross,et al. C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. , 2005, Current HIV research.
[64] Michael S. Seaman,et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 , 2015, Nature.
[65] B. Korber,et al. HIV-Host Interactions: Implications for Vaccine Design. , 2016, Cell host & microbe.
[66] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[67] A. Coutinho,et al. Negative selection of multireactive B cell clones in normal adult mice , 1994, European journal of immunology.
[68] Y. Kuroda,et al. Distinctive patterns of autoimmune response induced by different types of mineral oil. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[69] R. Palacios,et al. Human immunodeficiency virus infection and systemic lupus erythematosus , 2004, International journal of STD & AIDS.
[70] A. Cappione,et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.
[71] S. Akira,et al. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. , 2010, Journal of autoimmunity.
[72] M Anthony Moody,et al. Antibody polyspecificity and neutralization of HIV-1: a hypothesis. , 2006, Human antibodies.
[73] F. Pereyra,et al. A method for identification of HIV gp140 binding memory B cells in human blood. , 2009, Journal of immunological methods.
[74] C. Goodnow,et al. Cellular and genetic mechanisms of self tolerance and autoimmunity , 2005, Nature.
[75] N. Olsen,et al. IgG and IgM autoantibody differences in discoid and systemic lupus patients , 2012, The Journal of investigative dermatology.
[76] M. Nussenzweig,et al. Polyreactive antibodies in adaptive immune responses to viruses , 2011, Cellular and Molecular Life Sciences.
[77] M. Colonna,et al. Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response , 2010, The Journal of experimental medicine.
[78] I. McLean,et al. VACCINE POTENTIATION BY EMULSIFICATION WITH PURE HYDROCARBON COMPOUNDS. , 1963, Journal of immunology.
[79] J. Kappes,et al. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.
[80] Nico Pfeifer,et al. HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption , 2016, Nature.
[81] J. Sodroski,et al. Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3d , 2004, Journal of Virology.
[82] D. Wallace,et al. False-positive human immunodeficiency virus testing in patients with lupus erythematosus. , 1993, Seminars in arthritis and rheumatism.
[83] M. Satoh,et al. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane , 1994, The Journal of experimental medicine.
[84] F. Poccia,et al. Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice. , 1993, The Journal of infectious diseases.
[85] M. Nussenzweig,et al. Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses , 2011, PloS one.
[86] John P. Moore,et al. HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies. , 2016, Trends in immunology.
[87] J. Mascola,et al. Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants , 2006, Journal of Virology.
[88] S. Akira,et al. Contribution of Receptor Editing to the Antibody Repertoire , 2007 .
[89] B. Haynes,et al. HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.
[90] N. Letvin,et al. Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus. , 2000, Archives of internal medicine.
[91] A. Riva,et al. Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature , 2013, Clinical Rheumatology.
[92] T. Kepler,et al. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies , 2013, The Journal of experimental medicine.
[93] D. Littman,et al. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. , 1999, Science.
[94] J. Mascola,et al. Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates , 2013, Journal of Virology.